arrow
返回
E

Eric Lawitz

university of texas system

91H指数
592论文数
4.3W被引数
收录论文 46
发表时间
Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction-Associated Steatohepatitis临床试验:一项评估代谢功能障碍相关脂肪性肝炎单药疗法和联合治疗方案的第2期随机平台研究
err2025-11-01
err2
errOAAI
errFrias, Juan; Schmouder, Robert; Lawitz, Eric; Zhang, Yiming; Zhou, Heng; Badman, Michael K.; Ukomadu, Chinweike; Weiss, H. Markus; Zack, Julia; Yadav, Brijesh; Martic, Miljen; Drakeford, Clive; Koo, Phillip; Naoumov, Nikolai V.; Greenbaum, Linda E.
err分享
err收藏
Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatide在SYNERGY-NASH试验的事后分析中,tirzepatide在各个亚组中均显示出肝脏组织学的一致性改善
err2025-06-01
err0
errOAAI
errMark L. Hartman; Rohit Loomba; Eric J. Lawitz; Raj Vuppalanchi; Jérôme Boursier; Elisabetta Bugianesi; Masato Yoneda; Yuanyuan Tang; Bram Brouwers; Mathijs C. Bunck; Axel Haupt; Arun J. Sanyal
err分享
err收藏
Pharmacokinetics and Safety of Navitoclax in Hepatic ImpairmentNavitoclax的药代动力学和安全性研究(肝功能不全患者)
err2025-03-27
err0
PREAI
errPatel, Maulik; Potluri, Jalaja; Marbury, Thomas; Lawitz, Eric; Rondon, Juan Carlos; Hoffman, David M.; Siddani, Satya R.; Marsh, Kennan C.; Kim, Elaine J.; Uddin, Muhammad Erfan; Menon, Rajeev M.; Polepally, Akshanth R.
err分享
err收藏
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective解决代谢功能障碍相关的脂肪性肝病 (MASLD) 和代谢功能障碍相关的脂肪性肝炎 (MASH) 的全球高负担和不断上升: 从日益增长的患病率到支付方的角度
err2025-02-18
err0
PREAI
errYounossi, Zobair M.; Razavi, Homie; Sherman, Michael; Allen, Alina M.; Anstee, Quentin M.; Cusi, Kenneth; Friedman, Scott L.; Lawitz, Eric; Lazarus, Jeffrey V.; Schuppan, Detlef; Romero-Gomez, Manuel; Schattenberg, Joern M.; Vos, Miriam B.; Wong, Vincent Wai-Sun; Ratziu, Vlad; Hompesch, Marcus; Sanyal, Arun J.; Loomba, Rohit
err分享
err收藏
Effect of Target-Mediated Disposition on Iptacopan Clinical Pharmacokinetics in Participants with Normal or Impaired Hepatic Function
err2025-01-24
err0
errOAAI
errGetz, Elise Burmeister; Stein, Richard R.; Fink, Martin; Kulmatycki, Kenneth; Baltcheva, Irina; Weis, Wendy; Shah, Bharti; Lawitz, Eric; Schmouder, Robert
err分享
err收藏
Efficacy, tolerability and pharmacokinetics of survodutide, aglucagon/glucagon-like peptide-1 receptor dual agonist,in cirrhosis胰高血糖素/胰高血糖素样肽-1受体双重激动剂survodutide在肝硬化中的疗效,耐受性和药代动力学
err2024-11-01
err6
errOAAI
errLawitz, Eric J.; Fraessdorf, Mandy; Neff, Guy W.; Schattenberg, Joern M.; Noureddin, Mazen; Alkhouri, Naim; Schmid, Bernhard; Andrews, Charles P.; Takacs, Istvan; Hussain, Samina Ajaz; Fenske, Wiebke K.; Gane, Edward J.; Hosseini-Tabatabaei, Azadeh; Sanyal, Arun J.; Mazo, Daniel F.; Younes, Ramy
err分享
err收藏
A Phase 2 Randomized Trial of Survodutide in MASH and FibrosisSurvodutide在MASH和纤维化中的2期随机试验
err2024-07-25
err50
errOAAI
errSanyal, Arun J.; Bedossa, Pierre; Fraessdorf, Mandy; Neff, Guy W.; Lawitz, Eric; Bugianesi, Elisabetta; Anstee, Quentin M.; Hussain, Samina Ajaz; Newsome, Philip N.; Ratziu, Vlad; Hosseini-Tabatabaei, Azadeh; Schattenberg, Jorn M.; Noureddin, Mazen; Alkhouri, Naim; Younes, Ramy
err分享
err收藏
err分享
err收藏
Efficacy and Safety of Elafibranor in Primary Biliary CholangitisElafibranor在原发性胆汁性胆管炎中的疗效和安全性
err2024-02-29
err45
PREAI
errKowdley, Kris V.; Bowlus, Christopher L.; Levy, Cynthia; Akarca, Ulus S.; Alvares-da-Silva, Mario Reis; Andreone, Pietro; Arrese, Marco; Corpechot, Christophe; Francque, Sven M.; Heneghan, Michael A.; Invernizzi, Pietro; Jones, David; Kruger, Frederik C.; Lawitz, Eric; Mayo, Marlyn J.; Shiffman, Mitchell L.; Swain, Mark G.; Valera, Jose Miguel; Vargas, Victor; Vierling, John M.; Villamil, Alejandra; Addy, Carol; Dietrich, Julie; Germain, Jean-Michel; Mazain, Sarah; Rafailovic, Dragutin; Tadde, Bachirou; Miller, Benjamin; Shu, Jianfen; Zein, Claudia O.; Schattenberg, Jorn M.
err分享
err收藏
Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions非酒精性脂肪性肝炎的人工智能辅助数字病理学: 现状和未来方向
err2024-02-01
err18
errOAAI
errRatziu, Vlad; Hompesch, Marcus; Petitjean, Mathieu; Serdjebi, Cindy; Iyer, Janani S.; Parwani, Anil V.; Tai, Dean; Bugianesi, Elisabetta; Cusi, Kenneth; Friedman, Scott L.; Lawitz, Eric; Romero-Gomez, Manuel; Schuppan, Detlef; Loomba, Rohit; Paradis, Valerie; Behling, Cynthia; Sanyal, Arun J.
err分享
err收藏
Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH
err2024-01-31
err5
errOAAI
errAlkhouri, Naim; LaCerte, Carl; Edwards, Jeffrey; Poordad, Fred; Lawitz, Eric; Lee, Lois; Karan, Sharon; Sawhney, Sangeeta; Erickson, Mary; MacConell, Leigh; Zaru, Luna; Chen, Jianfen; Campagna, Jason
err分享
err收藏
A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis
err2023-11-06
err5
errOAAI
errNewsome, Philip N.; Sanyal, Arun J.; Neff, Guy; Schattenberg, Joern M.; Ratziu, Vlad; Ertle, Judith; Link, Jasmin; Mackie, Alison; Schoelch, Corinna; Lawitz, Eric
err分享
err收藏
Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib study
err2023-11-01
err7
errOAAI
errLawitz, Eric J.; Reiberger, Thomas; Schattenberg, Joern M.; Schoelch, Corinna; Coxson, Harvey O.; Wong, Diane; Ertle, Judith
err分享
err收藏
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis
err2023-11-01
err36
errOAAI
errSanyal, Arun J.; Ratziu, Vlad; Loomba, Rohit; Anstee, Quentin M.; Kowdley, Kris, V; Rinella, Mary E.; Sheikh, Muhammad Y.; Trotter, James F.; Knapple, Whitfield; Lawitz, Eric J.; Abdelmalek, Manal F.; Newsome, Philip N.; Boursier, Jerome; Mathurin, Philippe; Dufour, Jean-Francois; Berrey, M. Michelle; Shiff, Steven J.; Sawhney, Sangeeta; Capozza, Thomas; Leyva, Rina; Harrison, Stephen A.; Younossi, Zobair M.
err分享
err收藏
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
err2023-09-29
err7
errOAAI
errFlamm, Steven; Lawitz, Eric; Borg, Brian; Charlton, Michael; Landis, Charles; Reddy, K. Rajender; Shiffman, Mitchell; Alsina, Angel; Chang, Charissa; Ravendhran, Natarajan; Hernandez, Candido; Hezode, Christophe; Scherbakovsky, Stacey; Mercier, Renee-Claude; Samuel, Didier
err分享
err收藏
A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis
err2023-09-21
err19
errOAAI
errRinella, Mary E.; Lieu, Hsiao D.; Kowdley, Kris V.; Goodman, Zachary D.; Alkhouri, Naim; Lawitz, Eric; Ratziu, Vlad; Abdelmalek, Manal F.; Wong, Vincent Wai-Sun; Younes, Ziad H.; Sheikh, Aasim M.; Brannan, Donald; Freilich, Bradley; Membreno, Fernando; Sinclair, Marie; Melchor-Khan, Liza; Sanyal, Arun J.; Ling, Lei; Harrison, Stephen A.
err分享
err收藏